Solution-Phase Parallel Synthesis of Dissymmetric Disubstituted Malonamides Carrying Amino Ester Residues

Abstract

Amino esters were used as nucleophiles in the reaction with Meldrum’s acid to obtain monosubstituted malonic acids that reacted under coupling reaction conditions with a second different amino ester residue to give single >COCH₂CO< retropeptide units in high overall yields. The synthetic procedure led to the construction of a 4 × 5 combinatorial library of malonyl peptides.

amino acids - combinatorial chemistry - Meldrum’s ­acid - amides - retropeptides

References and Notes

1a Chorev M. Biopolymers  2005,  80:  67 

1b Fletcher MD. Campbell MM. Chem. Rev.  1998,  98:  763 

1c Zhao M. Kleinman HK. Mokotoff M. J. Pept. Res.  1997,  49:  240 

1d Chorev M. Goodman M. Trends Biotechnol.  1995,  13:  438 

1e Chorev M. Goodman M. Acc. Chem. Res.  1993,  26:  266 

2a Davis SS. In Perspectives in Medicinal Chemistry   Testa B. Kyburz E. Fuhrer W. Giger R. Verlag Helvetica Chimica Acta; Basel: 1993.  p.533 

2b Giannis A. Kolter T. Angew. Chem., Int. Ed. Engl.  1993,  32:  1244 

3a Biron Z. Khare S. Quadt SR. Hayek Y. Naider F. Anglister J. Biochemistry  2005,  44:  13602 

3b Schneider SE. Bray BL. Mader CJ. Friedrich PE. Anderson MW. Taylor TS. Boshernitzan N. Niemi TE. Fulcher BC. Whight SR. White JM. Greene RJ. Stoltenberg LE. Lichty M. J. Pept. Sci.  2005,  11:  744 

3c Veiga AS. Santos NC. Loura LMS. Fedorov A. Castanho MARB. J. Am. Chem. Soc.  2004,  126:  14758 

3d Wiley RA. Rich DH. Med. Res. Rev.  1993,  13:  327 

4a Gante J. Angew. Chem., Int. Ed. Engl.  1994,  33:  1699 

4b Grant SK. Meek TD. Metcalf BW. Petteway SR. Biomed. Appl. Biotechnol.  1993,  1:  325 

5a Trabocchi A. Menchi G. Guarna F. Machetti F. Scarpi D. Guarna A. Synlett  2006,  331 

5b Nefzi A. Ostresh JM. Yu J. Houghten RA. J. Org. Chem.  2004,  69:  3603 

5c Liu R. Marik J. Lam KS. Methods Enzymol.  2003,  369:  271 

5d Lam KS. Lehman AL. Song A. Doan N. Enstrom AM. Maxwell J. Liu R. Methods Enzymol.  2003,  369:  298 

5e Szostak JW. Chem. Rev.  1997,  97:  347 

6a Gibert L. Gonzalez A. Granell J. Lopez C. Tetrahedron: Asymmetry  2002,  13:  983 

6b Fujii H. Nishikawa N. Komazawa H. Suzuki M. Kojima M. Itoh I. Obata A. Ayukawa K. Azuma I. Saiki I. Clin. Exp. Metastasis  1998,  16:  94 

6c Fujii H. Nishikawa N. Komazawa H. Orikasa A. Ono M. Itoh I. Murata J. Azuma I. Saiki I. Oncol. Res.  1996,  8:  333 

7 Pallai PV. Richman S. Struthers RS. Goodman M. Int. J. Pept. Protein Res.  1983,  21:  84 

8a Nishikawa N. Komazawa H. Orikasa A. Yoshikane M. Yamaguchi J. Kojima M. Ono M. Itoh I. Azuma I. Fujii H. Murata J. Saiki I. Bioorg. Med. Chem. Lett.  1996,  6:  2725 

8b Dalpozzo A. Kanai K. Kereszturi G. Calabrese G. Int. J. Pept. Protein Res.  1993,  41:  561 

8c Verdini AS. Silvestri S. Becherucci C. Longobardi MG. Parente L. Peppoloni S. Perretti M. Pileri P. Pinori M. Viscomi GC. Nencioni L. J. Med. Chem.  1991,  34:  3372 

9a Kudo H. Sanda F. Endo T. Tetrahedron Lett.  2001,  42:  7847 

9b Phanstiel OIV. Lachicotte RJ. Torres D. Richardson M. Matsui H. Schaffer H. Adar F. Liu J. Seconi D. Chem. Mater.  2001,  13:  264 

9c Jain D. Tripathi M. Kohli DV. Uppadhyay RK. Arch. Pharmacol. Res  1992,  15:  184 

10 IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN), Eur. J. Biochem.  1984,  138:  9 

11 Gaber AE.-AM. McNab H. Synthesis  2001,  2059 

12 Rigo B. Fasseur D. Cauliez P. Couturier D. Tetrahedron Lett.  1989,  30:  3073 

13

The molar ratios of Meldrum’s acid to amino ester were a crucial point in order to avoid the undesired formation of a symmetric disubstituted malonamide.

14

By refluxing in toluene only the N-acetyl amino ester was obtained as a consequence of the decarboxylation reaction.

15

The reaction was monitored by IR and MS-Q-TOF every 30 min until completion.

16

Typical Experimental Procedure
Equimolar amounts (from 250 mg up to multigram scale) of a suitable amino ester hydrochloride and Et₃N were stirred in THF (3 mL/mmol) at r.t. After 30 min, a twofold excess of Meldrum’s acid was added, and then the reaction mixture was allowed to reflux for 3 h. After filtration and solvent removal, the malonic acid monoamides were obtained as crude products and used as such. The crude malonic acid monoamides were dissolved in CH₂Cl₂ and equimolar amounts of a suitable amino ester hydrochloride and DMAP were added. After stirring for 15 min, an equimolar amount of DCC was added and the mixture was stirred for additional 12 h. After reaction completion, the crude mixture was filtered and the expected malonyl peptides were collected as pure compounds after chromatography on silica gel (eluent mixture: hexane-EtOAc = 5:95).

17

Representative Spectral Data for 3A{1-4}B1
Methyl (2 S )-2-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)-3-phenylpropanoate (3A1B1)
Viscous oil. IR: 3442, 3328, 1739, 1679 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 2.92-3.18 (m, 2 H), 3.19 (s, 2 H), 3.64 (s, 3 H), 3.68 (s, 3 H), 3.96 (d, J = 5.4 Hz, 2 H), 4.71-4.82 (m, 1 H), 7.05-7.26 (m, 5 H), 7.62-7.76 (m, 2 H). ¹³C NMR (75 MHz, CDCl₃): δ = 37.6, 41.0, 42.1, 52.1 (two), 53.5, 126.8, 128.3, 129.0, 135.8, 167.0, 167.3, 169.8, 171.5. HRMS (ES Q-TOF): m/z calcd for C₁₆H₂₁N₂O₆ [M + H]⁺: 337.1394; found: 337.1387
Methyl (2 S )-2-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)propanoate (3A2B1)
Viscous oil. IR: 3424, 3326, 1744, 1678 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 1.36 (d, J = 7.2 Hz, 3 H), 3.28 (s, 2 H), 3.68 (s, 3 H), 3.69 (s, 3 H), 3.94-4.01 (m, 2 H), 4.42-4.56 (m, 1 H), 7.73 (d, J = 6.9 Hz, 1 H), 7.77-7.83 (m, 1 H). ¹³C NMR (75 MHz, CDCl₃): δ = 17.6, 41.1, 42.1, 52.2 (two), 52.3, 166.9, 167.6, 169.9, 173.0. HRMS (ES Q-TOF): m/z calcd for C₁₀H₁₇N₂O₆ [M + H]⁺: 261.1081; found: 261.1079 Methyl 3-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)propanoate (3A3B1)
Viscous oil. IR: 3445, 3327, 1737, 1679 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 2.42-2.48 (m, 2 H), 3.17 (s, 2 H), 3.37-3.44 (m, 2 H), 3.58 (s, 3 H), 3.63 (s, 3 H), 3.92 (d, J = 5.4 Hz, 2 H), 7.60-7.65 (m, 1 H), 7.92-7.94 (m, 1 H).¹³C NMR (75 MHz, CDCl₃): δ = 33.4, 34.8, 41.0, 42.2, 51.5, 51.9, 167.2, 167.7, 169.9, 172.2. HRMS (ES Q-TOF): m/z calcd for C₁₀H₁₇N₂O₆ [M + H]⁺: 261.1081; found: 261.1090
Methyl (2 S )-2-({3-[(2-Methoxy-2-oxoethyl)amino]-3-oxopropanoyl}amino)-3-methylbutanoate (3A4B1)
Viscous oil. IR: 3425, 3326, 1742, 1679 cm^-1. ¹H NMR (300 MHz, CDCl₃): δ = 0.88 (d, J = 6.6 Hz, 3 H), 0.90 (d, J = 6.6 Hz, 3 H), 2.10-2.20 (m, 1 H), 3.31 (s, 2 H), 3.70 (s, 3 H), 3.71 (s, 3 H), 4.00 (d, J = 5.4 Hz, 2 H), 4.41-4.48 (m, 1 H), 7.72 (d, J = 7.8 Hz, 1 H), 7.79 (d, J = 7.8 Hz, 1 H). ¹³C NMR (75 MHz, CDCl₃): δ = 17.7, 18.9, 30.8, 41.0, 42.0, 52.0, 52.2, 57.5, 167.2, 167.7, 169.9, 172.2. HRMS (ES Q-TOF): m/z calcd for C₁₂H₂₁N₂O₆ [M + H]⁺: 289.1394; found: 289.1401.

18 Ceretti S. Luppi G. De Pol S. Formaggio F. Crisma M. Toniolo C. Tomasini C. Eur. J. Org. Chem.  2004,  4188